Literature DB >> 21360016

Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin.

Kiyonari Kato1, Tomoki Kosugi1, Waichi Sato2, Hanayo Arata-Kawai1, Takenori Ozaki1, Naotake Tsuboi1, Isao Ito1, Hideo Tawada3, Yukio Yuzawa1, Seiichi Matsuo1, Kenji Kadomatsu4, Shoichi Maruyama1.   

Abstract

BACKGROUND: Growth factor Midkine (MK), which expresses on endothelial cells and renal proximal tubules, has been implicated in inflammation-related kidney diseases such as ischemic reperfusion-induced tubulointerstitial injury and diabetic nephropathy. The biological actions of MK are elicited through its chemotactic activity and chemokine-driven inflammatory pathway. Post-infectious glomerulonephritis is caused by the deposition of immune complexes into glomeruli by infiltrating a number of inflammatory cells. Therefore, we investigated whether MK might be involved in the pathogenesis of acute glomerulonephritis.
METHODS: We induced endocapillary proliferative glomerulonephritis in 129/SV mice using intraperitoneal injections of a large amount of protein.
RESULTS: In contrast to mice deficient in MK (Mdk (-/-)), Mdk (+/+) mice induced by protein overload demonstrated more diffuse cellular proliferation in the mesangial areas and capillary lumens, eventually leading to glomerular damage and tubulointerstitial injury. This pathological observation could be attributable to neutrophil infiltration through the chemotaxis and stimulation of the MK-macrophage inflammatory protein (MIP)-2 pathway, but appeared to be due to the MK-related immunoglobulin (Ig)G deposition and C3 activation. These findings are often seen in infectious-related glomerular injury. Furthermore, the profile of MK expression was strongly consistent with that of glomerular damage and tubulointersititial injury.
CONCLUSION: This study might provide a new insight into understanding the deleterious role of MK in endocapillary proliferative glomerulonephritis induced by protein overload.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360016     DOI: 10.1007/s10157-011-0408-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  18 in total

1.  Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour.

Authors:  E Nakamura; K Kadomatsu; S Yuasa; H Muramatsu; T Mamiya; T Nabeshima; Q W Fan; K Ishiguro; T Igakura; S Matsubara; T Kaname; M Horiba; H Saito; T Muramatsu
Journal:  Genes Cells       Date:  1998-12       Impact factor: 1.891

2.  Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.

Authors:  Hanayo Kawai; Waichi Sato; Yukio Yuzawa; Tomoki Kosugi; Seiichi Matsuo; Yoshifumi Takei; Kenji Kadomatsu; Takashi Muramatsu
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.

Authors:  A A Eddy; H Kim; J López-Guisa; T Oda; P D Soloway
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 4.  Understanding the nature of renal disease progression.

Authors:  G Remuzzi; P Ruggenenti; A Benigni
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

5.  Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.

Authors:  Tomoki Kosugi; Yukio Yuzawa; Waichi Sato; Hanayo Kawai; Seiichi Matsuo; Yoshifumi Takei; Takashi Muramatsu; Kenji Kadomatsu
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

6.  Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.

Authors:  Wuxing Zhang; Xiangmei Chen; Suozhu Shi; Ribao Wei; Jianzhong Wang; Nobuaki Yamanaka; Quan Hong
Journal:  Nephrol Dial Transplant       Date:  2005-03-08       Impact factor: 5.992

Review 7.  Inducible rodent models of acquired podocyte diseases.

Authors:  Jeffrey W Pippin; Paul T Brinkkoetter; Fionnualla C Cormack-Aboud; Raghu V Durvasula; Peter V Hauser; Jolanta Kowalewska; Ronald D Krofft; Christine M Logar; Caroline B Marshall; Takamoto Ohse; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10

Review 8.  Midkine and pleiotrophin in neural development and cancer.

Authors:  Kenji Kadomatsu; Takashi Muramatsu
Journal:  Cancer Lett       Date:  2004-02-20       Impact factor: 8.679

9.  Deletion of IL-18 receptor ameliorates renal injury in bovine serum albumin-induced glomerulonephritis.

Authors:  Masafumi Sugiyama; Koji Kinoshita; Kazuya Kishimoto; Hideki Shimazu; Yuji Nozaki; Shinya Ikoma; Masanori Funauchi
Journal:  Clin Immunol       Date:  2008-05-06       Impact factor: 3.969

Review 10.  Infection and glomerulonephritis.

Authors:  Saraladevi Naicker; June Fabian; Sagren Naidoo; Shoyab Wadee; Graham Paget; Stewart Goetsch
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

View more
  5 in total

Review 1.  Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.

Authors:  Delia Lidia Şalaru; Peter R Mertens; Peter Bartsch
Journal:  Int Urol Nephrol       Date:  2013-03-30       Impact factor: 2.370

Review 2.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 3.  Midkine in nephrogenesis, hypertension and kidney diseases.

Authors:  Waichi Sato; Yuka Sato
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  CD147/basigin reflects renal dysfunction in patients with acute kidney injury.

Authors:  Hiroshi Nagaya; Tomoki Kosugi; Mayuko Maeda-Hori; Kayaho Maeda; Yuka Sato; Hiroshi Kojima; Hiroki Hayashi; Noritoshi Kato; Takuji Ishimoto; Waichi Sato; Yukio Yuzawa; Seiichi Matsuo; Kenji Kadomatsu; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2013-12-04       Impact factor: 2.801

5.  Midkine: a novel and early biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.

Authors:  Jolanta Malyszko; Hanna Bachorzewska-Gajewska; Ewa Koc-Zorawska; Jacek S Malyszko; Grazyna Kobus; Slawomir Dobrzycki
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.